Comac Medical is gearing up for an exciting opportunity to participate in the Biotech Showcase 2025, taking place from January 13-15, 2025, in San Francisco, USA. As a premier investor conference for private and micro- to mid-cap biotechnology companies, Biotech Showcase 2025 offers a powerful platform to spotlight innovation and facilitate one-on-one engagements with investors and biopharmaceutical executives.

Now in its 17th year, Biotech Showcase has established itself as the must-attend event that kicks off the new year for life sciences. This influential event serves as a hub for knowledge sharing, business development, and strategic networking. Attendees can expect insightful panel discussions, expert-led workshops, and dedicated partnering sessions aimed at accelerating the advancement of life science projects.

Representing Comac Medical at this year’s Biotech Showcase are Vladimir Goranov, Co-CEO, and Thomas Dent, Business Development Director. With a wealth of experience in clinical research and business strategy, they are eager to engage with industry leaders, explore collaborative opportunities, and showcase Comac Medical’s comprehensive CRO and SMO services.

Biotech Showcase 2025 focuses on dynamic partnering opportunities, which allows for more direct, one-on-one interactions that lead to meaningful business connections and strategic alliances. Comac Medical is committed to leveraging this opportunity to strengthen partnerships, explore joint ventures, and support the development of groundbreaking therapies.

If you’re attending Biotech Showcase 2025, don’t miss the chance to connect with our team. Whether you’re seeking to discuss clinical outsourcing strategies, explore new partnership opportunities, or learn more about our tailored CRO and SMO services, Vladimir Goranov and Thomas Dent will be available for one-on-one meetings throughout the event. Join us at Biotech Showcase 2025!